These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28856900)

  • 21. Faecal immunochemical tests for haemoglobin: Analytical challenges and potential solutions.
    Benton SC; Symonds E; Djedovic N; Jones S; Deprez L; Kocna P; Maria Auge J;
    Clin Chim Acta; 2021 Jun; 517():60-65. PubMed ID: 33571484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the mass of sample loaded affect faecal haemoglobin concentration using the faecal immunochemical test?
    Piggott C; John C; Bruce H; Benton SC
    Ann Clin Biochem; 2018 Nov; 55(6):702-705. PubMed ID: 29792043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer.
    Fraser CG; Mathew CM; McKay K; Carey FA; Steele RJ
    Gut; 2008 Sep; 57(9):1256-60. PubMed ID: 18467371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer.
    Cole SR; Young GP; Esterman A; Cadd B; Morcom J
    J Med Screen; 2003; 10(3):117-22. PubMed ID: 14561262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
    Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
    Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic inconsistency of faecal immunochemical tests for haemoglobin in population screening of colorectal cancer.
    Huang Y; Ge W; London V; Li Q; Cai S; Zhang S; Zheng S
    Clin Chem Lab Med; 2013 Nov; 51(11):2173-80. PubMed ID: 24145058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
    Högberg C; Karling P; Rutegård J; Lilja M
    Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of faecal alpha-1-antitrypsin, haemoglobin and a chemical occult blood test in the detection of gastrointestinal disease.
    Moran A; Lawson N; Morrow R; Jones A; Asquith P
    Clin Chim Acta; 1993 Aug; 217(2):153-61. PubMed ID: 8261624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended?
    Haug U; Grobbee EJ; Lansdorp-Vogelaar I; Spaander MCW; Kuipers EJ
    Gut; 2017 Jul; 66(7):1262-1267. PubMed ID: 27006184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faecal haemoglobin concentrations by gender and age: implications for population-based screening for colorectal cancer.
    McDonald PJ; Strachan JA; Digby J; Steele RJ; Fraser CG
    Clin Chem Lab Med; 2011 Dec; 50(5):935-40. PubMed ID: 22149740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.
    Berger BM; Ahlquist DA
    Pathology; 2012 Feb; 44(2):80-8. PubMed ID: 22198259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients.
    Widlak MM; Thomas CL; Thomas MG; Tomkins C; Smith S; O'Connell N; Wurie S; Burns L; Harmston C; Evans C; Nwokolo CU; Singh B; Arasaradnam RP
    Aliment Pharmacol Ther; 2017 Jan; 45(2):354-363. PubMed ID: 27910113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidating bidirectional relationship between metabolic syndrome and elevated faecal haemoglobin concentration: a Taiwanese community-based cohort study.
    Ku MS; Fann JC; Chiu SY; Chen HH; Hsu CY
    BMJ Open; 2019 Mar; 9(3):e021153. PubMed ID: 30826754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of sample stability for a quantitative faecal immunochemical test and comparison of two sample collection approaches.
    Mellen S; de Ferrars M; Chapman C; Bevan S; Turvill J; Turnock D
    Ann Clin Biochem; 2018 Nov; 55(6):657-664. PubMed ID: 29534613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
    Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
    Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
    Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer diagnostic biomarkers: Beyond faecal haemoglobin.
    Krishnamoorthy A; Arasaradnam R
    Best Pract Res Clin Gastroenterol; 2023 Oct; 66():101870. PubMed ID: 37852713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance improvements of stool-based screening tests.
    van Dam L; Kuipers EJ; van Leerdam ME
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):479-92. PubMed ID: 20833351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.